quarter get psych buy
ebitda beat top line doj settlement clear overhang
ebitda incl minor interest est/consensu
better expect rev est/consensu store ss acut rev
except strong highest print sinc strong
volum price ss psych rev slow grow vs
better price vs less neg length
vs off-set wors admiss vs greater import
announc reach agreement principl depart
justic doj regard investig busi expect
settlement doj clear event help allevi length
lo admiss pressur open capit deploy opportun
maintain consensu est reiter buy rate rais
po ebitda vs ebitda roll forward
estim
ss margin segment psych rev moder
acut net rev estim better adj admiss
better revs/adj admit ss margin y/i vs
behavior net rev estimate adj patient day come
estimate rev/adj patient day came estimate margin improv
y/i vs flat neg signal cost
control
increas cap deploy share repo/high div
doj settlement clear way increas capit deploy
increas share repurchas program doubl quarterli dividend
under-lev balanc sheet plenti leverag capac
net dbt
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
inc own oper
acut care hospit behavior health center
ambulatori surgeri radiat oncolog center
oper acut care hospit
behavior health facil us uk
believ pois see
reacceler psych busi
depart justic doj settlement
meanwhil exposur higher growth acut
care market allow perform better
averag wait psych rebound
po base ebitda estim repres multipl
midpoint compani histor rang ebitda reflect better
expect perform behavior busi higher earn exposur
higher growth/return psych busi today histor period averag
upsid risk po larger expect demand tailwind behavior
busi addit unexpect feder fund behavior health program
exposur faster expect growth acut busi
downsid risk po continu delay psych rebound rise labor cost
gener weak backdrop util rise bad debt
kevin fischbeck cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
us facil hospit manag healthcar coverag cluster
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
